"So, this is not just a US issue. It's an issue that India faces and its relations with the EU, Australia, other countries," Wells told former US Ambassador to India, Richard Verma, during a virtual discussion organised by the Atlantic Council. She said there's a real opportunity for diversification as countries are looking to de-risk from China.
"India could make sense if the right policies are put in place and the right commitments to infrastructure," she said. The United States, she said certainly wants to see that happen and facilitate that kind of growth in its partnership with India. "But there are tough issues and this administration is committed to doing what is necessary to make progress," the American diplomat said.
Also read: Lockdown 4.0 Coronavirus Live Updates: COVID-19 cases cross 1,10 lakh as India limps back to normalcy
India and the United States, are working on a trade deal for the past two years. Last September, President Donald Trump had announced that it was likely to be signed soon. "In any trade relationship, there are trade irritants. This is an area where we've been working hard for the past two-three years. And it's a priority of the president to be able to reduce tariff barriers to American products," she said.
Expressing her disappointment that the two countries could not reach a trade deal earlier this year, she said the importance of such a deal has only increased as the Indian economy faces additional headwinds. "We have also seen backsliding. We've seen steps that have been taken over the course of the last year that disadvantage foreign companies that change the rules of the road after companies have made very sizable investments or that have levied taxes again in a discriminatory fashion on American firms," she rued.
Also read: Coronavirus effect: White House report tears into China for 'malicious activities'
"So, questions do continue to be raised about the degree to which India is prepared to open its markets," Wells said. Observing that ease of doing business is particularly important when it comes to the pharmaceutical sector, Wells said that the US was pleased to see Gilead's announcement last week that it's going to source remdesivir from Indian companies.
"As President Trump has noted, India is a vital partner for vaccine development. This is an area in which the Serum Institute of India is already working with US partners. And India is also a crucial cog in the global supply chain for ventilator components. We were pleased to be able ourselves to donate ventilators to India and other partners earlier this month," Wells said.
Earlier in the day, Wells told reporters during a conference call that India needs to open up as it is still a protected market, which sometimes denies a level playing field to foreign companies. "In the post-pandemic environment, countries are looking at a little bit of de-globalisation and onshoring of the critical production. And at the same time, there's a very vigorous effort to diversify supply chains," Wells said during a conference call with reporters.
"And this is a real moment of opportunity for India by adopting a more open and welcoming policies by reducing tariffs that allow manufacturing companies inside India to be part of the global supply chain," Wells added, stressing on building trusted supply chain relationships.
Also read: Coronavirus: Legislation tabled in Congress to bring American companies back from China